Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E C Hirsch

Showing results (11-20 of 157) with videos related to

Pageof 16
Sort By:
Parkinsonism & Related Disorders|November 19, 2008
How to improve neuroprotection in Parkinson's disease?E C Hirsch
Trends in Pharmacological Sciences|April 29, 2000
Nitric oxide, glial cells and neuronal degeneration in parkinsonismE C Hirsch, S Hunot
Advances in Neurology|September 14, 2001
Parkinson's disease. The apoptosis hypothesis revisitedA Hartmann, E C Hirsch
Annales Pharmaceutiques Francaises|January 12, 2015
In search of innovative therapeutics for neuropsychiatric disorders: the case of neurodegenerative diseasesJ Féger, E C Hirsch
Annals of Neurology|April 1, 2003
Neuroinflammatory processes in Parkinson's diseaseStephane Hunot, E C Hirsch
Movement Disorders : Official Journal of the Movement Disorder Society|June 5, 1998
Iron metabolism and Parkinson's diseaseE C Hirsch, B A Faucheux
Advances in Neurology|January 1, 1997
Neurochemical correlates of parkinsonism. Role of dopaminergic lesionsE C Hirsch, M T Herrero
Annales De Biologie Clinique|November 25, 1998
[Iron homeostasis and Parkinson's disease]B A Faucheux, E C Hirsch
Annals of Neurology|September 28, 1998
CD95 (APO-1/Fas) and Parkinson's diseaseA Hartmann, S Hunot, E C Hirsch
Functional Neurology|February 24, 2001
Mechanism of cell death in experimental models of Parkinson's diseaseE C Hirsch, S Hunot, A Hartmann
Pageof 16

Showing results (11-20 of 157) with videos related to

Sort By:
Pageof 16
Parkinsonism & Related Disorders|November 19, 2008
How to improve neuroprotection in Parkinson's disease?E C Hirsch
Trends in Pharmacological Sciences|April 29, 2000
Nitric oxide, glial cells and neuronal degeneration in parkinsonismE C Hirsch, S Hunot
Advances in Neurology|September 14, 2001
Parkinson's disease. The apoptosis hypothesis revisitedA Hartmann, E C Hirsch
Annales Pharmaceutiques Francaises|January 12, 2015
In search of innovative therapeutics for neuropsychiatric disorders: the case of neurodegenerative diseasesJ Féger, E C Hirsch
Annals of Neurology|April 1, 2003
Neuroinflammatory processes in Parkinson's diseaseStephane Hunot, E C Hirsch
Movement Disorders : Official Journal of the Movement Disorder Society|June 5, 1998
Iron metabolism and Parkinson's diseaseE C Hirsch, B A Faucheux
Advances in Neurology|January 1, 1997
Neurochemical correlates of parkinsonism. Role of dopaminergic lesionsE C Hirsch, M T Herrero
Annales De Biologie Clinique|November 25, 1998
[Iron homeostasis and Parkinson's disease]B A Faucheux, E C Hirsch
Annals of Neurology|September 28, 1998
CD95 (APO-1/Fas) and Parkinson's diseaseA Hartmann, S Hunot, E C Hirsch
Functional Neurology|February 24, 2001
Mechanism of cell death in experimental models of Parkinson's diseaseE C Hirsch, S Hunot, A Hartmann
Pageof 16